IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) Chairman Todd Hannigan purchased 300,000 shares of the business’s stock in a transaction on Monday, July 13th. The stock was purchased at an average price of $3.59 per share, for a total transaction of $1,077,000.00. Following the acquisition, the chairman owned 26,633,334 shares of the company’s stock, valued at approximately $95,613,669.06. This represents a 1.14% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Todd Hannigan also recently made the following trade(s):
- On Friday, July 10th, Todd Hannigan acquired 225,000 shares of IperionX stock. The shares were purchased at an average price of $3.58 per share, with a total value of $805,500.00.
- On Tuesday, April 28th, Todd Hannigan bought 220,000 shares of IperionX stock. The shares were purchased at an average cost of $4.48 per share, for a total transaction of $985,600.00.
- On Wednesday, April 29th, Todd Hannigan bought 260,000 shares of IperionX stock. The shares were purchased at an average cost of $4.20 per share, for a total transaction of $1,092,000.00.
IperionX Stock Down 3.2%
Shares of IPX opened at $24.67 on Thursday. The business’s fifty day moving average is $33.67 and its 200 day moving average is $37.25. IperionX Limited Sponsored ADR has a 12-month low of $21.66 and a 12-month high of $61.45. The company has a current ratio of 4.03, a quick ratio of 4.00 and a debt-to-equity ratio of 0.03.
Hedge Funds Weigh In On IperionX
Analysts Set New Price Targets
Several equities research analysts have recently commented on the stock. Alliance Global Partners reissued a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th. Roth Capital reaffirmed a “buy” rating on shares of IperionX in a research report on Monday, June 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st. Finally, BTIG Research boosted their price objective on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, June 5th. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, IperionX presently has a consensus rating of “Moderate Buy” and an average target price of $60.33.
Check Out Our Latest Analysis on IperionX
IperionX Company Profile
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Further Reading
- Five stocks we like better than IperionX
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
